Amélie Dendooven
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 4
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 8
- Chronic Kidney Disease and Diabetes 6
-
- Cancer Genomics and Diagnostics 5
-
- Connective Tissue Growth Factor Research 8
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Tri Q. NguyenRoel GoldschmedingRobbert J. KokJan Willem LeeuwisJaap A. JolesDionne M. van der GiezenDavid IsholaKarin G. F. Gerritsen
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Amélie Dendooven
53 papers receiving 861 citations
Peers
Comparison fields: 5 of 102
- Transplantation 125
- Nephrology 204
- Cancer Research 136
- Molecular Biology 351
- Obstetrics and Gynecology 39
Countries citing papers authored by Amélie Dendooven
This map shows the geographic impact of Amélie Dendooven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Dendooven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Dendooven more than expected).
Fields of papers citing papers by Amélie Dendooven
This network shows the impact of papers produced by Amélie Dendooven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Dendooven. The network helps show where Amélie Dendooven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amélie Dendooven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 20 | |
| 14 | 2018 | 58 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 9 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 4 | |
| 19 | 2014 | 27 | |
| 20 | 2012 | 27 |
About Amélie Dendooven
Amélie Dendooven is a scholar working on Nephrology, Health Informatics and Transplantation, having authored 61 papers that have together received 873 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (8 papers), Connective Tissue Growth Factor Research (8 papers), Chronic Kidney Disease and Diabetes (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Cancer Genomics and Diagnostics (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Transplantation (125 citations), Nephrology (204 citations) and Cancer Research (136 citations). Amélie Dendooven has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Tri Q. Nguyen, Roel Goldschmeding, Robbert J. Kok, Jan Willem Leeuwis, Jaap A. Joles, Dionne M. van der Giezen, David Ishola, Karin G. F. Gerritsen, Alferso C Abrahams and Steven Van Laecke. Their work appears in journals such as PLoS ONE, Advanced Drug Delivery Reviews and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.